Inhalable insulin is a powdered form of insulin, delivered with a nebulizer into the lungs where it is absorbed, generally more rapidly than subcutaneous insulin.

Afrezza, a monomeric inhaled insulin developed by Mannkind, was approved by the FDA in 2014...Wikipedia

 

 

Manufacturer's Website: Afrezza                                                                                                                 Average retail cost: $353/month

 

Search Terms: Afrezza, insulin human, Inhalation Powder, diabetes, DM